Narlaprevir
N/A
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameNarlaprevir
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2016/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesR-Pharm JscMerck Sharp & Dohme LLC
Active Indications
Inactive Indications